Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent

被引:33
作者
Barbeau, JM
Goforth, J
Caliendo, AM
Nolte, FS
机构
[1] Emory Univ Hosp, Emory Med Labs, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
关键词
D O I
10.1128/JCM.42.8.3739-3746.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We determined the dynamic range, reproducibility, accuracy, genotype bias, and sensitivity of the TaqMan hepatitis C virus (HCV) analyte-specific reagent (ASR). Serum samples were processed using the MagNA Pure LC instrument and run on the COBAS TaqMan 48 analyzer. The performance characteristics of the ASR were also compared with those of the qualitative AMPLICOR and quantitative AMPLICOR MONITOR HCV tests. The ASR exhibited a greater than or equal to6-log(10) linear dynamic range and excellent reproducibility, with a mean coefficient of variation of 14%. HCV RNA concentration measured with the ASR agreed within an average of 0.42 log(10) (2.6-fold) of the labeled concentration with members of a standard reference panel. HCV genotypes 1 to 4 were amplified with similar efficiencies with the ASR. The ASR and AMPLICOR MONITOR viral load results were significantly correlated (r = 0.8898; P < 0.01), but the agreement was poor (mean difference, 0.45 +/- 0.35 log(10)) for 72 HCV RNA-positive clinical samples. However, 98.9% agreement between the ASR and qualitative AMPLICOR test results was found with 60 positive and 29 negative samples. Limiting-dilution experiments demonstrated that the limits of detection for ASR and AMPLICOR tests were 84 and 26 IU/ml, respectively. The performance characteristics of the TaqMan HCV ASR are appropriate for all clinical applications of HCV RNA testing.
引用
收藏
页码:3739 / 3746
页数:8
相关论文
共 34 条
[1]  
[Anonymous], 1998, MMWR Recomm Rep, V47, P1
[2]  
[Anonymous], 1997, Fed Regist, V62, P62243
[3]  
[Anonymous], 2002, NIH Consens State Sci Statements, V19, P1
[4]   Performance of the new Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: Conversion to international units and comparison with the Roche COBAS amplicor HCV monitor, version 2.0, assay [J].
Beld, M ;
Sentjens, R ;
Rebers, S ;
Weegink, C ;
Weel, J ;
Sol, C ;
Boom, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :788-793
[5]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[6]  
Comanor L, 2001, AM J GASTROENTEROL, V96, P2968, DOI 10.1111/j.1572-0241.2001.04669.x
[7]   Second generation of the automated Cobas Amplicor HCV assay improves sensitivity of hepatitis C virus RNA detection and yields results that are more clinically relevant [J].
Doglio, A ;
Laffont, C ;
Caroli-Bosc, FX ;
Rochet, P ;
Lefebvre, JC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1567-1569
[8]  
Fiebelkorn KR, 2002, CLIN CHEM, V48, P1613
[9]  
Finney DJ., 1971, PROBIT ANAL
[10]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982